Image

Body Awareness in People With Depressive Disorder

Body Awareness in People With Depressive Disorder

Recruiting
18-69 years
All
Phase N/A

Powered by AI

Overview

Body awareness plays a crucial role in health and well-being. However, too little research has been carried out on how it manifests in individuals with depressive disorders. The Awareness Body Chart (ABC), a tool developed in recent years to assess body awareness, may provide new insights into the physical experience of people with depression and may lead the way in the application of body-oriented therapies in this cohort. Information about the distribution properties of the Awareness Body Chart in people with depressive disorder will be collected and analysed in this observational study.

Description

Research Questions:

  • Primary Research Question What are the distribution properties of the body awareness assessed by the ABC?
  • Secondary Research Questions (exploratory)
    1. Which factors (demographic, physical, psychological) correlate with body awareness?
    2. Does body awareness and mood change during an inpatient stay? Method: Observational Study Participants: 125 patients with depressive disorders at the beginning and end of an inpatient stay.

Assessments via Questionnaires:

Completion of questionnaires (partially with assistance) within the first 7 days after admission:

  • Demographic data and questions about health/relevant pre-existing conditions, including body weight and height, i.e. Body Mass Index
  • Awareness Body Chart (ABC)
  • Like/Dislike Body Chart (L/D-BC)
  • Self-Rating Mood Scale-Revised (Bf-SR)
  • Simple Physical Activity Questionnaire (SIMPAQ)
  • Short Form Health Survey (SF-12)
  • Brief Symptom Inventory (BSI)
  • Beck Depression Inventory II (BDI-II)
  • Insomnia Severity Index (ISI)

Pre-Discharge Questionnaire Completion:

  • ABC
  • L/D-BC
  • Bf-SR
  • BDI-II
  • ISI

Statistical Analysis:

For the analysis of the primary outcome, the ABC score for the entire sample will be presented using the mean and standard deviation or median and interquartile range, depending on the distribution properties of the ABC score. For the analysis of secondary questions, the total scores of the ABC and factor scores will be compared between men and women, between patients with and without pain, using t-tests or Mann-Whitney U-tests, and between individuals with different categories of depressive disorders or varying severities of depression using ANOVA or Kruskal-Wallis tests.

Furthermore, the correlation of body awareness with demographic data, body mass index, diagnosis group, disease duration, test results from SIMPAQ, SF-12, BSI, Bf-SR, and ISI will be investigated using correlation analyses, where the correlation coefficient will be calculated either using Pearson or Spearman, depending on the distribution of the data. Changes in body awareness and well-being during an inpatient stay will be analyzed using paired t-tests or Wilcoxon signed-rank tests.

Outlook

The study serves as a basis for further research on body awareness in individuals with depressive disorders.

Eligibility

Inclusion Criteria:

  • Age 18 - 69 years
  • Medical diagnosis of a depressive disorder, including depressive adjustment disorder and depressive episodes in the context of bipolar disorder, i.e. one of the following ICD-10 codes:
  • F32 Depressive Episode
  • F33 Recurrent Depressive Disorder
  • F31.3 Bipolar Affective Disorder, current mild or moderate depressive episode
  • F31.4 Bipolar Affective Disorder, current severe depressive episode without psychotic symptoms
  • F43.20 Adjustment Disorder with Brief Depressive Reaction
  • F43.21 Adjustment Disorder with Prolonged Depressive Reaction
  • Inpatient admission
  • Written informed consent

Exclusion Criteria:

  • Inability to fill out questionnaires with or without assistance due to language, physical, or cognitive limitations
  • Acute psychotic state
  • Known body schema disorders, e.g. due to significant neurological or malignant diseases, eating disorders, congenital or acquired physical limitations such as the absence of a body part
  • Deafness, blindness

Study details
    Depressive Disorder

NCT06879977

Johannes Kepler University of Linz

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.